Optometrists in Astoria, NY Accepting Medicare

51 Optometrists found. Showing 41 - 51

Dr. Chester Ng, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3285 33rd St Apt C3, Astoria, NY 11106 Phone: 562-650-8815

Dr. Roble Osman, O.D Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3117 23rd Ave Ste 2, Astoria, NY 11105 Phone: 718-626-9400

Mark Stadlen Optometrist Medicare: Medicare Enrolled Practice Location: 3803 Broadway, Astoria, NY 11103 Phone: 718-956-3000    Fax: 718-204-0227

Sahar Zelkha, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3803 Broadway, Astoria, NY 11103 Phone: 718-956-3000    Fax: 718-204-0227

Anna Dobrokhodova, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2425 29th St Apt 3f, Astoria, NY 11102 Phone: 646-547-2584

Odyssey Optical Inc Optometrist Medicare: Medicare Enrolled Practice Location: 2238 31st St, Astoria, NY 11105 Phone: 718-278-3600    Fax: 718-278-3865

Astoria Park Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 2556 Crescent St, Astoria, NY 11102 Phone: 718-344-1272    Fax: 718-425-9803

Dr. Stephanie Tituana, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2248 31st St, Astoria, NY 11105 Phone: 718-267-1333

Dr. Ahlam Chahid, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3117 23rd Ave, Astoria, NY 11105 Phone: 718-626-9400

Steven Neal Strom, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 22-38 31 Street, Odyssey Optical Inc, Astoria, NY 11105 Phone: 718-278-3600    Fax: 718-278-3865

Optimum Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3117 23rd Ave, Astoria, NY 11105 Phone: 718-626-9400    Fax: 718-626-9499

News Archive

Experimental flu vaccine produced using insect cells shows promise

An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine, according to a preliminary study in the April 11 issue of JAMA.

Human Genome Sciences receives FDA feedback for ZALBIN BLA

Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.

'Enlightened' atoms stage nano-riot againsts uniformity

When atoms in a crystal are struck by laser light, their electrons, excited by the light, typically begin moving back and forth together in a regular pattern, resembling nanoscale soldiers marching in a lockstep formation.

Key predictors for combination of alcohol use disorder and depression uncovered

For people with psychiatric disorders, comorbidity — or the presence of two or more disorders in a single patient — is quite common. One of the most common comorbidities is alcohol use disorder and major depressive disorder.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3(current)